tj0113
Small moleculeexperimental
Clinical trial activity
4 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Sep 18, 2024 (NCT06596005)
Timeline
Indications
Mechanism of action
TEAD1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07018245 | Phase 2 | Jul 9, 2025 | Government of China, Zhejiang University |
| NCT07012746 | N/A | Jun 7, 2025 | Fudan University, Government of China |
| NCT06832540 | Phase 1 | Feb 19, 2025 | Government of China |
| NCT06596005 | Phase 2 | Sep 18, 2024 | Government of China, Huzhou University, Nanchang University, Wenzhou Medical University, Zhejiang University |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 4 | 2 | 3 | 2024 |
| Zhejiang University | Academic/Hospital | 2 | 1 | 1 | 2024 |
| Fudan University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Huzhou University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Nanchang University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Wenzhou Medical University | Academic/Hospital | 1 | 0 | 1 | 2024 |
6 organizations
Page 1 / 1